DexCom Inc (DXCM)vsNeuroone Medical Technologies Corp (NMTC)
DXCM
DexCom Inc
$83.03
-1.75%
HEALTHCARE · Cap: $31.90B
NMTC
Neuroone Medical Technologies Corp
$1.56
-1.27%
HEALTHCARE · Cap: $14.75M
Smart Verdict
WallStSmart Research — data-driven comparison
DexCom Inc generates 39753% more annual revenue ($4.97B vs $12.47M). DXCM leads profitability with a 20.1% profit margin vs -59.7%. DXCM earns a higher WallStSmart Score of 74/100 (B).
DXCM
Strong Buy74
out of 100
Grade: B
NMTC
Avoid28
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 38 in profit
Keeps 20 of every $100 in revenue as profit
Strong operational efficiency at 24.3%
Earnings expanding 43.6% YoY
Conservative balance sheet, low leverage
16.3% revenue growth
Areas to Watch
Premium valuation, high expectations priced in
Trading at 11.9x book value
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -123.6% — below average capital efficiency
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : DXCM
The strongest argument for DXCM centers on Return on Equity, Profit Margin, Operating Margin. Profitability is solid with margins at 20.1% and operating margin at 24.3%. Revenue growth of 13.1% demonstrates continued momentum.
Bull Case : NMTC
The strongest argument for NMTC centers on Debt/Equity, Revenue Growth. Revenue growth of 16.3% demonstrates continued momentum.
Bear Case : DXCM
The primary concerns for DXCM are P/E Ratio, Price/Book.
Bear Case : NMTC
The primary concerns for NMTC are EPS Growth, Market Cap, Return on Equity.
Key Dynamics to Monitor
DXCM profiles as a mature stock while NMTC is a growth play — different risk/reward profiles.
DXCM carries more volatility with a beta of 1.42 — expect wider price swings.
NMTC is growing revenue faster at 16.3% — sustainability is the question.
DXCM generates stronger free cash flow (185M), providing more financial flexibility.
Bottom Line
DXCM scores higher overall (74/100 vs 28/100), backed by strong 20.1% margins and 13.1% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
DexCom Inc
HEALTHCARE · MEDICAL DEVICES · USA
DexCom, Inc. is a company that develops, manufactures, and distributes continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with headquarters in San Diego, California, and has a manufacturing facility in Mesa, Arizona.
Neuroone Medical Technologies Corp
HEALTHCARE · MEDICAL DEVICES · USA
NeuroOne Medical Technologies Corporation is a medical technology company. The company is headquartered in Eden Prairie, Minnesota.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?